Gavi, the Vaccine Alliance

Gavi, the Vaccine Alliance
Name	Gavi, the Vaccine Alliance
Founded	January 2000
Founder	Bill & Melinda Gates Foundation, World Health Organization, UNICEF, World Bank
Location	Geneva, Switzerland
Key people	José Manuel Barroso (Chair), Seth Berkley (former CEO)
Focus	Immunization, Global health
Website	https://www.gavi.org/

Gavi, the Vaccine Alliance. It is a public–private global health partnership committed to increasing access to immunization in poor countries. Founded at the World Economic Forum in 2000, the alliance brings together implementing country governments, donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, and philanthropic organizations like the Bill & Melinda Gates Foundation. Its core mission is to save lives and protect people's health by improving equitable and sustainable use of vaccines.

History and formation

The alliance was formally launched in January 2000 following growing recognition of a significant immunization gap between wealthy and developing nations. Key founding partners included the Bill & Melinda Gates Foundation, which provided an initial pledge of US$750 million, alongside major United Nations agencies like the World Health Organization and UNICEF, and the World Bank. The creation was championed by figures such as Bill Gates and former Nelson Mandela, who highlighted the moral and economic imperative. The early strategy focused on accelerating the introduction of new and underused vaccines, such as those for Hepatitis B and Haemophilus influenzae type b, into the national programs of the world's poorest countries. Its formation marked a shift towards innovative financing mechanisms in global health, moving beyond traditional aid models.

Mission and objectives

Gavi's primary mission is to save children's lives and protect people's health by increasing access to immunization in low-income countries. Its strategic goals are to accelerate the uptake and coverage of new and existing vaccines, strengthen health systems to deliver immunization, and shape vaccine markets to ensure sustainability and affordability. A key objective is supporting the introduction of vaccines against major causes of child mortality, including pneumococcal disease, rotavirus, and human papillomavirus. The alliance also plays a critical role in global outbreak response, notably through funding for the Ebola vaccine and support for COVID-19 vaccination via the COVAX facility. Equity is a central tenet, aiming to reach "zero-dose" children missed by routine services.

Governance and funding

The alliance is governed by a Board of Directors that includes representatives from donor governments like the United States and the United Kingdom, implementing country governments, independent technical experts, civil society organizations, the World Health Organization, UNICEF, the World Bank, and the vaccine industry. Day-to-day operations are managed by a Secretariat headquartered in Geneva, Switzerland. Funding is mobilized through periodic replenishment conferences, with major donors including governments, the Bill & Melinda Gates Foundation, and private sector partners. Innovative financing instruments, such as the International Finance Facility for Immunisation and the Gavi Advance Market Commitment, leverage capital markets and donor pledges to secure predictable, long-term funding for vaccine procurement.

Programs and impact

Gavi supports countries through comprehensive programs including vaccine financing, health system strengthening grants, and technical assistance. It has facilitated the immunization of over 1 billion children since its inception, preventing more than 17 million future deaths according to its estimates. Major initiatives include the Pentavalent vaccine rollout, support for malaria vaccine introduction in sub-Saharan Africa, and the massive COVID-19 vaccine delivery effort through COVAX. The alliance's market-shaping efforts have helped reduce vaccine prices and encourage manufacturer competition. Its impact is measured through increased Diphtheria-tetanus-pertussis vaccine coverage and the reduction of deaths from vaccine-preventable diseases in supported countries.

Partnerships and stakeholders

The alliance operates as a complex partnership model, coordinating a diverse array of stakeholders. Core partners include the World Health Organization, which sets normative policy, and UNICEF, the world's largest vaccine purchaser and distributor. Implementing countries, primarily eligible nations in Africa and Asia, are central stakeholders. The private sector is engaged through vaccine manufacturers like Pfizer and the Serum Institute of India, as well as corporate partners. Research institutions, such as the Johns Hopkins Bloomberg School of Public Health, provide technical expertise. Civil society organizations, including the International Federation of Red Cross and Red Crescent Societies, support community outreach and accountability.

Criticism and challenges

Despite its achievements, Gavi has faced criticism and navigated significant challenges. Some analysts argue its focus on specific vaccines can distort national health priorities and strain fragile health systems. Concerns have been raised about transparency and the influence of private donors, particularly the Bill & Melinda Gates Foundation, on the global health agenda. The alliance's reliance on co-financing from recipient countries has sometimes been difficult for the poorest nations to meet. Major operational challenges include reaching the last-mile populations in conflict zones like Yemen or remote regions, maintaining cold chain infrastructure, and combating vaccine hesitancy. The COVID-19 pandemic exposed equity issues within COVAX, as high-income countries secured bilateral deals, slowing vaccine delivery to lower-income nations.

Category:Global health organizations Category:Vaccination Category:Organizations based in Geneva